Top Ann Arbor, MI Biotech Companies (32)
Don't see your company?
Create a company profile
Official LinkedIn page for Esperion. Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines accessible. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit esperion.com and follow us on Twitter at www.twitter.com/EsperionInc. Community guidelines: https://bit.ly/3vLCGdO
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
Accord Biomaterials, Inc. develops chemistries and coatings for medical device protection. It offers Nogen that are catalytic nitric oxide
OcuSciences is developing a technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction.
Swift Biosciences develops molecular biology reagents for research and diagnostic applications.
Akadeum Life Sciences, an emerging life science startup, is located in Ann Arbor, MI. Founded in 2014, Akadeum was established to create advanced isolation products and to fundamentally change the way that isolating chemical and biological targets is approached. At Akadeum, we strive to disrupt the status quo by delivering a technology that can isolate any sample, any volume, anywhere.
Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.
Arbor Assays specializes in the development of high sensitivity assay kits, high-purity inhibitors, and antibodies for drug discovery and basic research. Products for research in non-invasive endocrinology, mitochondrial dysfunction, oxidative stress, cell signaling biomarkers, kidney damage, cholinesterase activity, and other areas are readily available. We also offer custom assay development and testing services. We make unique kits to measure cGAMP, P450, AChE and BChE Activity among others.
MMS is an award-winning, global clinical research organization (CRO) that supports leading pharmaceutical and biotech companies as well as many smaller enterprises across our spectrum of services. Having completed more than 50 submissions for drug approval over the last 5 years, we remain a top choice for sponsors who are looking for innovation and demand high quality from their CRO partners. Senior leadership at MMS has more than two decades of hands-on drug development experience which helps support program-level strategy and execution of projects across multiple therapeutic areas. Continual staff training, innovative recruitment and motivating career opportunities help MMS retain the best talent and develop a strong, client-focused workforce across all global locations. Our mission is to deliver high-quality services, rooted in good science and decades of regulatory experience, that will assist our clients in developing and marketing life-changing therapies, thereby positively affecting patients' lives worldwide.
MI Bioresearch is a contract research organization providing in vivo preclinical imaging services.
OncoFusion Therapeutics is engaged in the R&D of personalized therapeutics for patients with genetically defined cancers.
Helping Make Research Possible We are helping make research possible by supplying scientists worldwide with the assay kits, antibodies, proteins, and biochemicals to advance their research. We know the scientific community needs more than our products, so our 100 in-house scientists, the same who design and develop our products, connect with researchers to answer questions, provide resources, and offer contract research services. We offer tools for diverse research areas, including cancer, inflammation, nitric oxide, neuroscience, epigenetics, diabetes, apoptosis, oxidative injury, endocrinology, atherosclerosis, and many more. We are also a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.
Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation.
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted
Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.
Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.
Everist Health is a medicine company developing technologies focused on cancer, cardiovascular diseases and diabetes.
We create high-performing biobased ingredients and materials from sustainable processes at the best value for our customers.
Work Your Passion. Live Your Purpose.
